In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.

A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive symptoms in 34 adults with major depressive disorder, according to a ...

How are the first state-run psilocybin therapy programs going? Plus, psilocybin clinical trials for cancer patients dealing ...

Mushcanyon 10X is a high-potency functional mushroom blend designed to elevate focus, energy, and overall wellness naturally. Formulated with powerful adaptogenic mushrooms, it supports peak mental ...

Oregon lawmakers are advancing a sweeping health care overhaul that would reshape nearly every corner of the system — from ...

Curious about microdosing mushrooms? If you’re seeking real science, thoughtful discussion, and grounded guidance instead of just hype, this is for you. Join the seasoned plant medicine nurses of ...

About 10 million US adults microdosed psilocybin, LSD, or MDMA in 2025, a new probability-based, nationally representative ...